Table 2 Estimated posterior odds ratios of patient characteristics associated with the intended adjuvant therapies, and relative weights between therapies
| Â | Â | Median posterior odds ratios [95 % CrIa] | ||
|---|---|---|---|---|
Factors | N | Radiotherapy | Chemotherapy | Hormonal Therapy |
Road travelling time (TRACT) | Â | Â | Â | Â |
<1 h | 4514 | 1.00 | 1.00 | 1.00 |
1−<2 h | 502 | 0.88 [0.56, 1.39] | 0.74 [0.46, 1.19] | 0.94 [0.68, 1.31] |
2−<4 h | 750 | 0.66 [0.42, 1.04] | 0.91 [0.58, 1.45] | 0.97 [0.70, 1.35] |
4−<6 h | 317 | 0.41 [0.23, 0.74] | 0.44 [0.25, 0.81] | 0.74 [0.49, 1.08] |
6 or more h | 274 | 0.41 [0.24, 0.73] | 0.60 [0.34, 1.07] | 0.71 [0.48, 1.04] |
Socio-economic status (IRSAD) | Â | Â | Â | Â |
Quintile 1 Most disadvantaged | 817 | 0.94 [0.65, 1.36] | 0.73 [0.50, 1.04] | 1.01 [0.77, 1.32] |
Quintile 2 | 1458 | 0.80 [0.56, 1.12] | 0.86 [0.62, 1.19] | 0.91 [0.71, 1.15] |
Quintile 3 | 1762 | 1.03 [0.76, 1.39] | 0.91 [0.69, 1.20] | 1.01 [0.81, 1.26] |
Quintile 4 | 1539 | 0.92 [0.68, 1.24] | 0.93 [0.70, 1.22] | 1.03 [0.83, 1.28] |
Quintile 5 Most advantaged | 781 | 1.00 | 1.00 | 1.00 |
Age at diagnosis (years) | Â | Â | Â | Â |
40–49 | 933 | 1.07 [0.85, 1.34] | 1.85 [1.51, 2.27] | 0.83 [0.71, 0.98] |
50–59 | 2064 | 1.00 | 1.00 | 1.00 |
60–69 | 2074 | 0.86 [0.72, 1.03] | 0.50 [0.42, 0.60] | 1.20 [1.06, 1.37] |
70–89 | 1225 | 0.36 [0.29, 0.44] | 0.12 [0.09, 0.16] | 1.39 [1.18, 1.63] |
Indigenous status | Â | Â | Â | Â |
Non-Indigenous | 5467 | 1.00 | 1.00 | 1.00 |
Indigenous | 63 | 1.66 [0.83, 3.49] | 1.16 [0.61, 2.17] | 1.33 [0.89, 2.04] |
Indigenous unknown | 766 | 0.87 [0.69, 1.10] | 0.40 [0.30, 0.53] | 1.06 [0.89, 1.26] |
Marital status | Â | Â | Â | Â |
Married | 4150 | 1.00 | 1.00 | 1.00 |
Never married | 305 | 0.78 [0.57, 1.09] | 0.79 [0.56, 1.10] | 0.85 [0.68, 1.08] |
Widowed/Divorced/Separated | 1665 | 0.83 [0.71, 0.99] | 0.95 [0.80, 1.14] | 1.05 [0.92, 1.19] |
Marital unknown | 176 | 0.91 [0.59, 1.44] | 1.05 [0.62, 1.73] | 0.91 [0.67, 1.24] |
Tumour stage | Â | Â | Â | Â |
Localised (Stage I) | 4081 | 1.00 | 1.00 | 1.00 |
Advanced (Stage II, III, IV) | 2139 | 2.43 [2.03, 2.90] | 11.21 [9.60, 13.05] | 0.87 [0.77, 0.97] |
Stage unknown | 76 | 0.59 [0.32, 1.08] | 2.83 [1.42, 5.42] | 1.24 [0.84, 1.88] |
Occupation | Â | Â | Â | Â |
Blue collar | 245 | 1.71 [1.18, 2.48] | 1.03 [0.71, 1.48] | 0.98 [0.76, 1.27] |
White collar | 907 | 1.48 [1.18, 1.87] | 1.19 [0.96, 1.47] | 1.11 [0.95, 1.31] |
Professional | 1061 | 1.49 [1.21, 1.84] | 1.38 [1.13, 1.71] | 1.09 [0.94, 1.28] |
Not in the labour force | 2631 | 1.00 | 1.00 | 1.00 |
Unknown | 1452 | 1.28 [1.06, 1.55] | 1.05 [0.85, 1.29] | 1.27 [1.10, 1.47] |
Invasive tumour type | Â | Â | Â | Â |
Invasive ductal | 4074 | 1.00 | 1.00 | 1.00 |
Tubular | 167 | 0.48 [0.33, 0.71] | 0.27 [0.12, 0.55] | 0.91 [0.68, 1.21] |
Lobular classical | 506 | 0.95 [0.74, 1.22] | 0.73 [0.56, 0.95] | 1.72 [1.40, 2.12] |
Other | 434 | 0.73 [0.56, 0.96] | 0.77 [0.57, 1.03] | 0.94 [0.78, 1.15] |
Unknown | 1115 | 0.81 [0.67, 0.98] | 0.69 [0.57, 0.84] | 0.70 [0.61, 0.80] |